We are live on
!
Find out more
AI
Alphabet Inc Portfolio holdings
AUM
$99.1B
1-Year Est. Return
124.46%
This Fund
S&P 500
This Quarter
Est. Return
+7.55%
1 Year Est. Return
+124.46%
3 Year Est. Return
+326.82%
5 Year Est. Return
+231.24%
10 Year Est. Return
+1,201.66%
AUM
$99.1B
AUM Growth
+$95.1B
(+2,367%)
Cap. Flow
+$93.8B
Cap. Flow
% of AUM
94.64%
Top 10 Holdings %
Top 10 Hldgs %
99.54%
Holding
29
New
3
Increased
–
Reduced
4
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$93.6B |
| 2 |
PBLS
Parabilis Medicines Inc
PBLS
|
+$136M |
| 3 |
FRVO
Fervo Energy
FRVO
|
+$63.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revolution Medicines
RVMD
|
+$50.5M |
| 2 |
Monte Rosa Therapeutics
GLUE
|
+$5.89M |
| 3 |
LIFE
Ethos Technologies Inc
LIFE
|
+$2.66M |
| 4 |
Relay Therapeutics
RLAY
|
+$2.24M |
| 5 |
Tenaya Therapeutics
TNYA
|
+$632K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 96.23% |
| 2 | Technology | 1.88% |
| 3 | Healthcare | 1% |
| 4 | Financials | 0.84% |
| 5 | Utilities | 0.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPCX
1
SpaceX
SPCX
$1.87T
| $94.2B | 95.05% |
+551,189,500
| New | +$93.6B |
|
2
Planet Labs
PL
$7.12B
| $1.17B | 1.18% |
35,248,893
| – | – |
|
3
AST SpaceMobile
ASTS
$17.4B
| $795M | 0.8% |
8,943,486
| – | – |
|
4
CME Group
CME
$103B
| $769M | 0.78% |
3,484,020
| – | – |
|
5
Arm
ARM
$255B
| $695M | 0.7% |
1,960,784
| – | – |
|
|
6
Revolution Medicines
RVMD
$44.6B
| $552M | 0.56% |
2,946,619
-345,906
| -11% | -$50.5M |
|
7
Freshworks
FRSH
$3.62B
| $164M | 0.17% |
16,206,643
| – | – |
|
|
PBLS
8
Parabilis Medicines Inc
PBLS
$4.83B
| $135M | 0.14% |
+4,919,498
| New | +$136M |
|
|
TEM
9
Tempus AI
TEM
$11.6B
| $89.9M | 0.09% |
1,551,102
| – | – |
|
10
GitLab
GTLB
$7.58B
| $83.2M | 0.08% |
2,724,712
| – | – |
|
11
UiPath
PATH
$9.4B
| $76.5M | 0.08% |
7,034,337
| – | – |
|
|
LIFE
12
Ethos Technologies Inc
LIFE
$2.46B
| $65.7M | 0.07% |
3,622,604
-147,552
| -4% | -$2.66M |
|
13
Prime Medicine
PRME
$655M
| $61.1M | 0.06% |
16,562,498
| – | – |
|
|
FRVO
14
Fervo Energy
FRVO
$4.35B
| $51.5M | 0.05% |
+1,760,732
| New | +$63.6M |
|
|
PAYP
15
PayPay
PAYP
$10.3B
| $44.8M | 0.05% |
3,125,000
| – | – |
|
|
MAZE
16
Maze Therapeutics
MAZE
$1.52B
| $41.4M | 0.04% |
1,388,583
| – | – |
|
|
17
Relay Therapeutics
RLAY
$4.11B
| $26.4M | 0.03% |
1,410,029
-154,144
| -10% | -$2.24M |
|
|
BBOT
18
BridgeBio Oncology
BBOT
$701M
| $21.5M | 0.02% |
2,823,126
| – | – |
|
19
Oscar Health
OSCR
$9.4B
| $13.7M | 0.01% |
481,988
| – | – |
|
20
Beam Therapeutics
BEAM
$3.03B
| $11M | 0.01% |
321,604
| – | – |
|
21
Vera Therapeutics
VERA
$2.46B
| $10.4M | 0.01% |
241,264
| – | – |
|
22
Sana Biotechnology
SANA
$1.18B
| $9.82M | 0.01% |
2,812,500
| – | – |
|
|
23
Monte Rosa Therapeutics
GLUE
$1.14B
| $9.01M | 0.01% |
372,474
-311,801
| -46% | -$5.89M |
|
24
Lyell Immunopharma
LYEL
$356M
| $4.12M | ﹤0.01% |
293,256
| – | – |
|
|
FIG
25
Figma
FIG
$15.4B
| $3.9M | ﹤0.01% |
215,582
| – | – |
|
Similar funds
Alphabet Inc's Q2 2026 Portfolio in Review
As of Q2 2026, Alphabet Inc held 29 positions worth $99.1B, up 2,367% from $4.02B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Alphabet Inc deployed $93.8B of net new capital in Q2 2026, opening 3 new positions. Its largest new stake was SpaceX: 551,189,500 shares worth $94.2B.
By sector, the portfolio is most concentrated in Industrials at 96% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Revolution Medicines, an estimated $50.5M trimmed.
- Alphabet Inc's largest Q2 2026 buy was SpaceX: 551,189,500 shares worth $94.2B.
- Alphabet Inc's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $50.5M.
- Alphabet Inc fully exited Tenaya Therapeutics in Q2 2026, selling an estimated $632K.
- Alphabet Inc's ten largest holdings make up 100% of its $99.1B portfolio in Q2 2026.
- Alphabet Inc opened 3 new positions and closed 1 in Q2 2026.
- Alphabet Inc's portfolio value rose 2,367% quarter-over-quarter to $99.1B.
Based on Alphabet Inc's 13F filing for Q2 2026, filed 7 Aug 2026.